Non-alcoholic steatohepatitis in children and adolescents

Medical Journal of Australia

Volumn 173, Issue 9, 2000, Pages 476-479

  Manton, N D ^a   Lipsett, J ^a   Moore, D J ^a   Davidson, G P ^a   Bourne, A J ^a   Couper, R T L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MALE; OBESITY; STEATOSIS;

EID: 0034613642     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139299.x     Document Type: Article

References (20)

1. Idiopathic steatohepatitis in childhood: A multicentre retrospective study
2. Nonalcoholic steatohepatitis in children
3. Review: Nonalcoholic steatohepatitis
4. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population
5. Nonalcoholic steatohepatitis
6. Change in body mass index in Australian primary school children, 1985-1997
7. Nonalcoholic steatohepatitis, a study of 49 patients
8. The natural history of nonalcoholic fatty liver: A follow-up study
9. Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler
10. Prognosis in nonalcoholic steatohepatitis
11. Recurrence of nonalcoholic steatohepatitis following liver transplantation
12. Cryptogenic cirrhosis: Clinical characterisation and risk factors for underlying disease
13. Liver fibrosis in overweight patients
14. Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III)
15. Relative antioxidant deficiency in obese children: A weighty contributor to morbidity?
16. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study
17. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis
18. Gastrointestinal disturbances with obesity
19. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study